Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-1.23%
SPX
-1.60%
IXIC
-2.24%
FTSE
-0.70%
N225
-0.66%
AXJO
-0.92%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap
878.71M
Dividend Yield
0.00%
P/E Ratio
-2.34
EPS
-1.29
Revenue
164.07M
Avg. Volume
17.44M

Recently from Cashu

publisher logo
Cashu

Iovance Biotherapeutics: Request for Content Summary Not Provided

7 days ago
publisher logo
Cashu

Iovance Biotherapeutics: Analysts Split on Future Amid Clinical Trial Developments

8 days ago
publisher logo
Cashu

Iovance Biotherapeutics Pioneers Tumor-Infiltrating Lymphocyte Therapy in Cancer Treatment

16 days ago

About

What does IOVA do?
Iovance Biotherapeutics, based in San Carlos, California, specializes in cell therapies for cancer, focusing on its lead product, Amtagvi, for melanoma treatment. The company employs 557 people and went public in 2008.
Sector
💻 Health Care
IPO
CEO
Employees
838 employees
Headquarters
California, USA
Website
http://www.iovance.com
Stocks
Health Care
iova
Iovance Biotherapeutics
NASDAQ: IOVA
+0.12 (+4.47%)
2.685
USD
At close at Aug 01, 20:41 UTC
Summary
News
Signals
Benchmarks
Financials